含脱氢松香骨架的1,8-萘酰亚胺衍生物的合成及其对阴离子的识别

以歧化松香胺为原料合成了6个新型含脱氢松香骨架的1,8-萘酰亚胺衍生物2a～2b和3a～3d,其结构用1H NMR,13C NMR,MS和元素分析进行了表征.对3a～3d进行了阴离子识别研究,并对其识别机理进行了讨论.     

新型多取代Tr(o)ger's base衍生物的合成及其晶体结构

以邻氨基二苯甲酮为原料,经两分子环化缩合反应制得6,12-二芳基二苯并[b,f][1,5]二氮杂环辛四烯(2a~2d);2a~2d经LiAlH4还原制得6,12-二芳基-5,6,11,12-四氢二苯并[b,f][1,5]二氮杂环辛(3a~3d);3a~3d与醛(或酮)反应,合成了一系列新型的多取代Tr(o)ger's base衍生物(4a~4d和5a~7a),其结构经1H NMR, 13C NMR, HR-MS(ESI)和X-射线单晶衍射表征.通过分析架桥前后3a(CCDC: 1498564)和6a(CCDC: 1498555)的晶体结构,解释了该类化合物1H NMR中NCH质子及桥上取代基质子裂分的原因,并进一步证实了4~7为非C2轴对称结构.     

含双哌啶基手性β-氨基醇的合成及其在二乙基锌与芳香醛加成中的手性诱导作用

合成了五个含双哌啶基的手性β-氨基醇化合物(2a,2b,4b~4d),其结构经1H NMR,13C NMR,IR和MS表征,其中4b~4d未见文献报道。2和4在二乙基锌对芳香醛的不对称加成反应中均显示出优良的手性诱导作用,以苯甲醛为底物时,所得仲醇的ee值最高达93.1%。     

新型二氢叶酸还原酶抑制剂的合成及生物活性测试

以氯乙腈和2-噻吩甲醛为原料,通过接合经缩合、环合、还原、硝化等步骤合成的两个关键中间体1c和2d,设计合成了两个新型二氢叶酸还原酶抑制剂的衍生物3c和4b,其结构经1H NMR、13C NMR和MS方法验证.采用噻唑蓝法对目标化合物进行了抗肿瘤活性测试,结果表明3c对筛选的5种肿瘤细胞株的抑制活性均比阳性对照药洛美曲索、甲氨蝶呤和培美曲塞强,4b对Hep-G2的抑制活性比阳性对照药洛美曲索、甲氨蝶呤和培美曲塞强,而且3c和4b对正常细胞株——人脐带内皮血管平滑肌细胞的抑制活性明显比甲氨蝶呤和培美曲塞弱.     

环糊精相转移催化水相高效合成糖基三氮唑

以水为溶剂,β-环糊精为相转移催化剂,β-D-葡萄炔丙苷(或木糖炔丙苷)和叠氮化物在一价铜催化下经CuAAC反应合成了一系列糖基三氮唑衍生物(4a~4d或5a~5d),收率78%~95%,其结构经1H NMR,13C NMR,2D NOESY和ESI-MS表征。其中4b,4c和5a~5d为新化合物。该反应具有高度的立体专一性和区域选择性。     

新型多取代Trger’s base衍生物的合成及其晶体结构

以邻氨基二苯甲酮为原料,经两分子环化缩合反应制得6,12-二芳基二苯并[b,f][1,5]二氮杂环辛四烯(2a~2d);2a~2d经Li Al H4还原制得6,12-二芳基-5,6,11,12-四氢二苯并[b,f][1,5]二氮杂环辛(3a~3d);3a~3d与醛(或酮)反应,合成了一系列新型的多取代Trger’s base衍生物(4a~4d和5a~7a),其结构经1H NMR,13C NMR,HR-MS(ESI)和X-射线单晶衍射表征。通过分析架桥前后3a(CCDC:1498564)和6a(CCDC:1498555)的晶体结构,解释了该类化合物1H NMR中NCH质子及桥上取代基质子裂分的原因,并进一步证实了4~7为非C2轴对称结构。     

手性硫脲叔胺催化不对称Michael加成反应合成α,α-双取代芳基氨基酸前体

手性硫脲-叔胺催化剂(1)催化α-取代硝基乙酸酯与丙烯醛发生Michael加成反应,合成了一系列α,α-双取代芳基氨基酸前体(4a～4j),其结构经1H NMR,13C NMR和ESI-HR-MS表征.以合成4b为例,考察了溶剂,反应温度和反应时间等对反应的影响,结果表明,在1 10 mol%,甲苯为溶剂,于-60 ℃反应100 h的最佳反应条件下,4b的收率94%,74%e.e..并合成了一系列4b的衍生物.     

稠杂环化合物的研究(Ⅷ)——3-(α-萘亚甲基)-6-烷基/芳基均三唑并[3,4-b]-1,3,4-噻二唑的合成及生物活性研究

合成了15个新的3-(α-萘亚甲基)-6-烷基/芳基均三唑并[3,4-b]-1,3,4-噻二唑,经EA、JR、~1H NMR和MS确定其组成和结构,并对其代表物4b、4d、4f和4g的抗菌、除草、植物生长调节活性进行了初步观察。     

活性小分子DHMBA含氮衍生物的合成及其抑菌活性

以没食子酸甲酯为原料,通过甲基化、还原反应制得牡蛎中的活性小分子DHMBA,并进一步通过PCC氧化、缩合反应合成其含氮衍生物(4a～4d);为进行构效分析,分别选用与DHMBA分子结构相近的丁香醛和2,3,4-三羟基苯甲醛作为原料,通过缩合反应制得一系列含氮衍生物(5a～5d)和(6a～6d),其结构经¹H NMR, ¹³C NMR和HR-MS(ESI)表征。采用滤纸片法测试了化合物2～6对大肠杆菌和金黄色葡萄球菌的抑制活性。结果表明:在10～40 mg·mL^-1内,化合物4～6对受试菌种均表现出一定的抑制活性,其中4b、 6b和6d的抑菌活性最为显著。      

硫（醇）代N-对甲苯基/苯基磺酰基氨基羧酸酯类化合物的合成与神经营养活性

根据官能团的组合,设计合成了硫（醇）代N-对甲苯基/苯基磺酰基氨基羧酸酯类化合物,这些化合物的结构¹H NMR, ¹³C NMR, MS 和 HRMS证实,初步的实验结果表明：在10μg/mL浓度下,化合物4a, 4b, 4d, 5c, 5d, 5g, 6b和 6d显示对PC12细胞缺氧损伤具有显著的保护作用,化合物4c, 5b和 6c显示对PC12细胞缺氧损伤具有一定的保护作用;在5μg/mL浓度下,4d和 6d显示对PC12细胞缺氧损伤具有一定的保护作用;初步的实验也表明：在10μg/mL浓度下,4c, 5a, 5c, 5d, 5e和 6b显示对PC12细胞具有一定的促分化作用。     

Pinastric acid revisited: a complete NMR and X-ray structure assignment

Chemical investigation of a terrestrial lichen has yielded the pulvinic acid derivative pinastric acid (4). The structure of 4 was secured by detailed spectroscopic analysis as well as via a single X-ray diffraction study. This is the first report of the X-ray structure and 2D NMR assignment of pinastric acid (4). Pinastric acid (4) displayed antitumour, antiviral and antimicrobial (both antibacterial and antifungal) activities. Whilst the antiviral and antimicrobial activities are consistent with previous findings of 4 this is the first report of the antitumour properties for the compound.     

Synthesis and Antimicrobial Studies of New Bis[4,5‐dihydro‐1‐phenyl‐5‐thienyl‐3‐(phenyl‐4‐alkoxy)‐1H‐pyrazole] Derivatives

Syntheses and antimicrobial behavior of the alkyl linked new bispyrazolines 4a , 4b , 4c , 4d , 4e , 4f , 4g have been investigated. These compounds exhibited better antimicrobial activities as compared with their corresponding bischalcones. The structures of the prepared compounds ( 3a , 3b , 3c , 3d , 3e , 3f , 3g and 4a , 4b , 4c , 4d , 4e , 4f , 4g ) were determined from the rigorous analysis of their IR, ¹H NMR, ¹³C NMR, and mass spectral parameters.     

Synthesis and antibacterial activities of pleuromutilin derivatives

Six new pleuromutilin derivatives were designed and synthesized, confirmed by MS, IR and 1H NMR techniques. And the antibacterial activities were primarily evaluated in vitro. The results indicated that most of the derivatives showed more potent activities against corresponding bacterial strains than that of pleuromutilin. Especially, compounds 4d and 5b had obvious activities against salmonella compared with pleuromutifin.     

新型六氢吡啶-2,3-并吲哚化合物的合成及其抗肿瘤活性

以3-取代氧化吲哚与丙烯酸酯为原料,经Michael加成反应制得中间体--3-丙酸酯取代氧化吲哚（3a~3d）; 3a~3d与甲胺发生酰胺化反应制得3 丙酰胺取代氧化吲哚（4a~4d）; 4a~4d用氢化铝锂还原-环化,合成了4个六氢吡啶-2,3-并吲哚化合物(5a~5d）; 5a和5b用氢化铝锂还原合成了2个六氢吡啶-2,3-并吲哚化合物（6a和6b）, 5a～5d, 6a和6b均为新化合物,总产率42%～61%,其结构经¹H NMR, ¹³C NMR和HR-ESI-MS表征。采用MTT法研究了5a～5d, 6a和6b对人肺癌细胞（A549）,人前列腺（PC-3）和人白血病细胞（K562）的体外抗肿瘤活性。结果表明：5b对A549, PC 3和K562的抑制活性均较好,其IC₅₀分别为27.2μmol·L^-1, 37.5 μmol·L^-1和21.7 μmol·L^-1。     

新型1,2,3-三唑类化合物的合成及抗菌构效关系

根据活性基团拼接原理, 以4-取代-苯胺为原料, 经重氮化、 关环和缩合反应合成了17个化合物1-(4-取代苯基)-5-取代苯基亚氨基-4-取代-1,2,3-三唑(7a~7c和13a~13d)和1-(4-取代苯基)-5-取代苄基氨基-4-取代-1,2,3-三唑(5a~5c, 10a~10c和14a~14d), 其中化合物5a~5c, 7b, 7c, 10a, 10c, 13b~13d和14b~14c为新化合物, 对所制备化合物的结构进行了表征. 生物活性测试结果表明, 所有化合物均表现出一定的抑菌活性, 对大肠杆菌的抑菌活性均优于氟康唑; 化合物7a和10c对金黄色葡萄球菌的抑制活性明显优于氟康唑; 而化合物13a和13d则对白色念球菌表现出良好的抑制活性, 与三氯生相当.     

Synthesis and Antifungal Activities of Novel Strobilurin Derivatives Containing Quinolin-2(1H)-one Moiety

To discover novel lead compounds with better antifungal activities, a series of novel strobilurin derivatives containing quinolin-2(1H)-one moiety was designed and synthesized via intermediate derivatization method. Their structures were characterized by means of ¹H nuclear magnetic resonance(¹H NMR), ¹³C NMR and high resolution mass spectrometry(HRMS). The biological assay results indicate that most target compounds exhibit good to excellent fungicidal activities against 10 plant pathogens. Compounds 4d, 5b and 5c possess 94.1%, 83.8% and 80.9% in vitro inhibition respectively against Rhizotonia cereals at the concentration of 50 μg/mL, which are better than that of the control agents. Especially, the inhibition activities of compound 4d against all of the tested fungi approach or exceed those of the controls. The structure-activity relationship was also discussed.     

环己基(三甲基硅基亚甲基)锡二芳香酸酯的合成、结构和抗癌活性

采用环己基(三甲基硅基亚甲基)二氯化锡和芳香酸(物质的量比1:2)在三乙胺存在下,合成了8种新的混合二烃基锡化合物环己基(三甲基硅基亚甲基)锡二芳香酸酯。 通过IR、¹H NMR、¹³C NMR和元素分析等技术手段对它们的结构进行了表征;部分化合物的生物活性测定初步结果表明,它们对肺腺癌细胞(A549)有较好的体外抗癌活性,抑制率均在75%以上。     

Microwave assisted synthesis of disubstituted benzyltin arylformylhydrazone complexes: anticancer activity and DNA‐binding properties

Eight disubstituted benzyltin complexes, i.e., {[R(O)C=N‐N=C (Me)COO]R'₂Sn(CH₃OH)}_n ( 1a and 2b ), {[R(O)C=N‐N=C (Me)COO]R'₂Sn(CH₃OH)}₂ ( 1b and 1d ) and {[R(O)C=N‐N=C (Me)COO]R'₂Sn}_n ( 1c , 2a , 2c , and 2d ) (R = C₄H₃O‐, C₄H₃S‐, p–t‐Bu‐C₆H₄‐ or p‐MeO‐C₆H₄‐; R' = o‐Cl‐C₆H₄CH₂‐ or o‐Me‐C₆H₄CH₂‐), were prepared from the reaction of arylformylhydrazine, pyruvic acid and disubstituted benzyltin dichloride with microwave irradiation. All complexes were characterized by FT‐IR spectroscopy, ¹H, ¹³C and ¹¹⁹Sn NMR spectroscopy, HRMS, elemental analysis, X‐ray single‐crystal diffraction and TGA. The in vitro antitumour activities of all complexes were evaluated by an MTT assay against three human cancer cell lines (NCI‐H460, HepG2, and MCF7). 2b exhibited strong antitumour activity on HepG2 cells and was expected to be a suitable platform for further chemical optimization to develop as anticancer therapeutics. The DNA binding of 2b was studied by UV–visible absorption spectrometry, fluorescence competitive assays, viscosity measurements and gel electrophoresis. Molecular docking was used to predict the binding between 2b and DNA, and the results show that 2b can become embedded in the double helix of DNA and cleave DNA.     

Synthesis and antimicrobial activities of new 4,6‐diaryl‐ 4,5‐dihydro‐3‐hydroxy‐2H‐indazoles

A series of new 4,6‐diaryl‐4,5‐dihydro‐3‐hydroxy‐2H‐indazoles 5a , 5b , 5c , 5d , 5e , 5f , 5g , 5h , 5i , 5j , 5k were synthesized by the cyclization of ethyl 2‐oxo‐4,6‐diarylcyclohex‐3‐ene carboxylates 4a , 4b , 4c , 4d , 4e , 4f , 4g , 4h , 4i , 4j , 4k . The compounds were characterized by IR, ¹H NMR, ¹³C NMR, 2D NMR, and elemental analysis. The synthesized compounds were evaluated for in vitro antibacterial and antifungal activities against Staphylococcus aureus, Escherichia coli, Salmonella typhimurium, Pseudomonas aeruginosa, Candida albicans, Aspergillus niger, Aspergillus flavus, and Rhizopus sp. Most of the compounds exhibited good activity against the tested organisms. J. Heterocyclic Chem.,, (2012).